Back to search

National and Kapodistrian University of Athens

Ασφάλεια και αποτελεσματικότητα της διαδερμικής θερμοκαυτηρίασης με ραδιοσυχνότητες σε ασθενείς με ανεγχείρητες ηπατικές μεταστάσεις από αδενοκαρκίνωμα του παχέος εντέρου

Abstract

dc:description

Despite the advent of combination chemotherapy regimens achieved within the last decade, long term survival of patients with unresectable metastatic disease from colorectal cancer remains poor. Thermal ablation procedures, including radiofrequency ablation (RFA), are considered feasible options in treating unresectable hepatic tumors either primary (hepatocellular carcinoma) or metastatic, the latter mainly arising from colorectal cancer. Percutaneous access is the least invasive RFA procedure. Local ablation therapies of hepatic tumors have become increasingly popular. Their advantages of outpatient management, low morbidity and synergy with chemotherapy are coupled with evidence that their scope extends beyond palliation for selected patients. However, there is still debate on optimal time and patient selection, and the published literature lacks randomized data on efficacy compared to chemotherapy alone.We performed a retrospective, case-controlled study of patients with colorectal liver metastases that were treated with percutaneous radiofrequency (RF) or microwave (MW) thermal ablation (cases). We assigned 28 consecutive patients treated with RFA or MW to an age-sex matched group of patients with comparable characteristics that received chemotherapy only.A total of 55 sessions (52 RF, 3 MW) were performed among cases, with minimal procedural time (median 8 min), zero mortality and no severe complications (3 cases of local hepatic hematoma not requiring hospitalization). Thermal ablation was associated with prolonged median progression-free survival (PFS, 19.4 months) and overall survival (OS, 27.5 months) over controls (14.0 and 21.4 months, respectively). After adjusting for hepatic involvement, PFS estimates were similar between the two groups and OS was better for the ablated group. One and 2-year survival estimates were 0.96 and 0.79, respectively for thermal ablation patients compared to 0.82 and 0.52 for controls. In summary, percutaneous thermal ablation procedures may add significantly to the management of patients with colorectal liver metastasis, delaying disease progression and death. Importantly, the improvement of systemic therapies may expand the pool of candidate patients for modern local therapies rather than diminish it. Thermal ablation should be considered a significant improvement in the multidisciplinary approach of patients with colorectal cancer and limited hepatic involvement.

Degree

thesis:*
Grantor dc:publisher
National and Kapodistrian University of Athens
Year dc:date
2014

Author and committee

dc:creator, dc:contributor.*
Authors dc:creator
  • Poulou, Loukia
  • Πούλου, Λουκία

Subjects

dc:subject × 14

Rights

Language dc:language
gre

Identifiers

dc:identifier.*
Identifier
10.12681/eadd/42027

Chain of custody

source
Harvested from
Greek National Archive of PhD Theses
Base URL
phdtheses.ekt.gr/eadd_oai/request
Last updated
2026-11-18
Source record
OAI-PMH GetRecord
citation

Poulou, Loukia; Πούλου, Λουκία. Ασφάλεια και αποτελεσματικότητα της διαδερμικής θερμοκαυτηρίασης με ραδιοσυχνότητες σε ασθενείς με ανεγχείρητες ηπατικές μεταστάσεις από αδενοκαρκίνωμα του παχέος εντέρου. National and Kapodistrian University of Athens, 2014. http://hdl.handle.net/10442/hedi/42027